• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒模拟细胞膜包覆的纳米颗粒用于 mRNA 的细胞质递送。

Virus-Mimicking Cell Membrane-Coated Nanoparticles for Cytosolic Delivery of mRNA.

机构信息

Department of NanoEngineering, Chemical Engineering Program, Moores Cancer Center, University of California San Diego, La Jolla, CA, 92093, USA.

出版信息

Angew Chem Int Ed Engl. 2022 Jan 10;61(2):e202113671. doi: 10.1002/anie.202113671. Epub 2021 Nov 29.

DOI:10.1002/anie.202113671
PMID:34694684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8727555/
Abstract

Effective endosomal escape after cellular uptake represents a major challenge in the field of nanodelivery, as the majority of drug payloads must localize to subcellular compartments other than the endosomes in order to exert activity. In nature, viruses can readily deliver their genetic material to the cytosol of host cells by triggering membrane fusion after endocytosis. For the influenza A virus, the hemagglutinin (HA) protein found on its surface fuses the viral envelope with the surrounding membrane at endosomal pH values. Biomimetic nanoparticles capable of endosomal escape were fabricated using a membrane coating derived from cells engineered to express HA on their surface. When evaluated in vitro, these virus-mimicking nanoparticles were able to deliver an mRNA payload to the cytosolic compartment of target cells, resulting in the successful expression of the encoded protein. When the mRNA-loaded nanoparticles were administered in vivo, protein expression levels were significantly increased in both local and systemic delivery scenarios. We therefore conclude that utilizing genetic engineering approaches to express viral fusion proteins on the surface of cell membrane-coated nanoparticles is a viable strategy for modulating the intracellular localization of encapsulated cargoes.

摘要

细胞摄取后的有效内涵体逃逸是纳米递药领域的一个主要挑战,因为大多数药物有效负载必须定位于除内涵体以外的亚细胞隔室,才能发挥作用。在自然界中,病毒可以通过内吞作用后触发膜融合,将其遗传物质轻易递送到宿主细胞的细胞质中。对于甲型流感病毒,其表面上的血凝素 (HA) 蛋白在内涵体 pH 值下使病毒包膜与周围膜融合。使用源自表面表达 HA 的工程细胞衍生的膜涂层来制备能够实现内涵体逃逸的仿生纳米颗粒。在体外评估时,这些模拟病毒的纳米颗粒能够将 mRNA 有效负载递送到靶细胞的细胞质隔室,从而成功表达编码蛋白。当将负载 mRNA 的纳米颗粒在体内给药时,在局部和全身递送情况下,蛋白质表达水平均显著增加。因此,我们得出结论,利用基因工程方法在细胞膜涂层纳米颗粒的表面表达病毒融合蛋白是一种可行的策略,可用于调节封装货物的细胞内定位。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/8727555/b36d825a4a25/nihms-1751820-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/8727555/201230c4c1f7/nihms-1751820-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/8727555/fa5879545cc1/nihms-1751820-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/8727555/94c931915856/nihms-1751820-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/8727555/3bd70ece3cba/nihms-1751820-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/8727555/b36d825a4a25/nihms-1751820-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/8727555/201230c4c1f7/nihms-1751820-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/8727555/fa5879545cc1/nihms-1751820-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/8727555/94c931915856/nihms-1751820-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/8727555/3bd70ece3cba/nihms-1751820-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2333/8727555/b36d825a4a25/nihms-1751820-f0006.jpg

相似文献

1
Virus-Mimicking Cell Membrane-Coated Nanoparticles for Cytosolic Delivery of mRNA.病毒模拟细胞膜包覆的纳米颗粒用于 mRNA 的细胞质递送。
Angew Chem Int Ed Engl. 2022 Jan 10;61(2):e202113671. doi: 10.1002/anie.202113671. Epub 2021 Nov 29.
2
Acid-induced membrane fusion by the hemagglutinin protein and its role in influenza virus biology.血凝素蛋白介导的酸诱导膜融合及其在流感病毒生物学中的作用。
Curr Top Microbiol Immunol. 2014;385:93-116. doi: 10.1007/82_2014_393.
3
HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3.H5N1 和 H7N9 流感病毒对人内皮细胞的 HA 依赖性嗜性由 HA 的稳定性降低决定,这使病毒能够应对内体酸化效率低下和组成型表达的 IFITM3。
J Virol. 2019 Dec 12;94(1). doi: 10.1128/JVI.01223-19.
4
A histidine residue of the influenza virus hemagglutinin controls the pH dependence of the conformational change mediating membrane fusion.流感病毒血凝素的一个组氨酸残基控制介导膜融合的构象变化的pH依赖性。
J Virol. 2014 Nov;88(22):13189-200. doi: 10.1128/JVI.01704-14. Epub 2014 Sep 3.
5
Unique Infectious Strategy of H5N1 Avian Influenza Virus Is Governed by the Acid-Destabilized Property of Hemagglutinin.H5N1禽流感病毒独特的感染策略受血凝素的酸不稳定特性支配。
Viral Immunol. 2017 Jul/Aug;30(6):398-407. doi: 10.1089/vim.2017.0020. Epub 2017 Jun 27.
6
Receptor binding and pH stability - how influenza A virus hemagglutinin affects host-specific virus infection.受体结合与pH稳定性——甲型流感病毒血凝素如何影响宿主特异性病毒感染。
Biochim Biophys Acta. 2014 Apr;1838(4):1153-68. doi: 10.1016/j.bbamem.2013.10.004. Epub 2013 Oct 24.
7
Modulation of the pH Stability of Influenza Virus Hemagglutinin: A Host Cell Adaptation Strategy.流感病毒血凝素pH稳定性的调节:一种宿主细胞适应策略。
Biophys J. 2016 Jun 7;110(11):2293-2301. doi: 10.1016/j.bpj.2016.04.035.
8
Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore.流感病毒血凝素细胞质结构域的修饰影响融合孔的扩大。
J Virol. 2000 Aug;74(16):7529-37. doi: 10.1128/jvi.74.16.7529-7537.2000.
9
Chemically Designed Nanoscale Materials for Controlling Cellular Processes.化学设计的纳米材料用于控制细胞过程。
Acc Chem Res. 2021 Jul 20;54(14):2916-2927. doi: 10.1021/acs.accounts.1c00215. Epub 2021 Jul 7.
10
The role of fusion activity of influenza A viruses in their biological properties.甲型流感病毒融合活性在其生物学特性中的作用。
Acta Virol. 2016 Jun;60(2):121-35. doi: 10.4149/av_2016_02_121.

引用本文的文献

1
Programmable self-replicating JEV nanotherapeutics redefine RNA delivery in ALS.可编程的自我复制日本脑炎病毒纳米疗法重新定义了肌萎缩侧索硬化症中的RNA递送。
Commun Biol. 2025 Aug 26;8(1):1282. doi: 10.1038/s42003-025-08579-7.
2
NIR light-driven transformable liquid metal-based nanovaccines restrain postoperative colorectal cancer recurrence.近红外光驱动的可转化液态金属基纳米疫苗可抑制结直肠癌术后复发。
Bioact Mater. 2025 Jun 25;51:774-786. doi: 10.1016/j.bioactmat.2025.06.037. eCollection 2025 Sep.
3
Nerve growth factor-loaded biomimetic prussian blue nanocomplexes for reversing osteoporosis via promoting osteoblast precursor cell proliferation and differentiation.

本文引用的文献

1
Genetically engineered cell membrane-coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs.基因工程细胞膜包裹的纳米颗粒,用于将地塞米松靶向递送至发炎的肺部。
Sci Adv. 2021 Jun 16;7(25). doi: 10.1126/sciadv.abf7820. Print 2021 Jun.
2
Drug Targeting Platelet Membrane-Coated Nanoparticles.药物靶向:血小板膜包被纳米颗粒
Small Struct. 2020 Oct;1(1). doi: 10.1002/sstr.202000018. Epub 2020 Sep 9.
3
The dawn of mRNA vaccines: The COVID-19 case.mRNA 疫苗的黎明:COVID-19 案例。
负载神经生长因子的仿生普鲁士蓝纳米复合物通过促进成骨细胞前体细胞增殖和分化来逆转骨质疏松症
Mater Today Bio. 2025 May 22;32:101898. doi: 10.1016/j.mtbio.2025.101898. eCollection 2025 Jun.
4
Improving tumor treatment: Cell membrane-coated nanoparticles for targeted therapies.改善肿瘤治疗:用于靶向治疗的细胞膜包覆纳米颗粒
Mater Today Bio. 2025 Apr 23;32:101716. doi: 10.1016/j.mtbio.2025.101716. eCollection 2025 Jun.
5
Overcoming Biological Barriers in Cancer Therapy: Cell Membrane-Based Nanocarrier Strategies for Precision Delivery.克服癌症治疗中的生物屏障:基于细胞膜的纳米载体精准递送策略
Int J Nanomedicine. 2025 Mar 13;20:3113-3145. doi: 10.2147/IJN.S497510. eCollection 2025.
6
Engineered neutrophil membrane-camouflaged nanocomplexes for targeted siRNA delivery against myocardial ischemia reperfusion injury.工程化中性粒细胞膜伪装纳米复合物用于靶向递送siRNA以对抗心肌缺血再灌注损伤
J Nanobiotechnology. 2025 Feb 22;23(1):134. doi: 10.1186/s12951-025-03172-w.
7
Developing mRNA Nanomedicines with Advanced Targeting Functions.开发具有先进靶向功能的信使核糖核酸纳米药物。
Nanomicro Lett. 2025 Feb 21;17(1):155. doi: 10.1007/s40820-025-01665-9.
8
A DNA origami-based enzymatic cascade nanoreactor for chemodynamic cancer therapy and activation of antitumor immunity.一种用于化学动力学癌症治疗和激活抗肿瘤免疫的基于DNA折纸的酶促级联纳米反应器。
Sci Adv. 2025 Jan 10;11(2):eadr9196. doi: 10.1126/sciadv.adr9196. Epub 2025 Jan 8.
9
Engineered Macrophage Membrane-Coated S100A9-siRNA for Ameliorating Myocardial Ischemia-Reperfusion Injury.工程化巨噬细胞膜包裹 S100A9-siRNA 改善心肌缺血再灌注损伤。
Adv Sci (Weinh). 2024 Nov;11(41):e2403542. doi: 10.1002/advs.202403542. Epub 2024 Sep 12.
10
Biomimetic Nucleic Acid Drug Delivery Systems for Relieving Tumor Immunosuppressive Microenvironment.用于缓解肿瘤免疫抑制微环境的仿生核酸药物递送系统
Pharmaceutics. 2024 Aug 1;16(8):1028. doi: 10.3390/pharmaceutics16081028.
J Control Release. 2021 May 10;333:511-520. doi: 10.1016/j.jconrel.2021.03.043. Epub 2021 Mar 30.
4
Engineered Cell-Membrane-Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity.工程化细胞膜包覆纳米颗粒直接呈递肿瘤抗原以促进抗癌免疫。
Adv Mater. 2020 Jul;32(30):e2001808. doi: 10.1002/adma.202001808. Epub 2020 Jun 15.
5
Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA.通过全身纳米颗粒介导的 PTEN mRNA 递送来恢复体内肿瘤生长抑制。
Nat Biomed Eng. 2018 Nov;2(11):850-864. doi: 10.1038/s41551-018-0284-0. Epub 2018 Sep 17.
6
Lysosomal protease deficiency or substrate overload induces an oxidative-stress mediated STAT3-dependent pathway of lysosomal homeostasis.溶酶体蛋白酶缺乏或底物过载会诱导一种氧化应激介导的 STAT3 依赖性溶酶体动态平衡途径。
Nat Commun. 2018 Dec 17;9(1):5343. doi: 10.1038/s41467-018-07741-6.
7
Highly Pathogenic Avian H7N9 Influenza Viruses: Recent Challenges.高致病性禽流感 H7N9 病毒:最新挑战。
Trends Microbiol. 2019 Feb;27(2):93-95. doi: 10.1016/j.tim.2018.11.008. Epub 2018 Dec 12.
8
The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery.纳米颗粒的内体逃逸:迈向更有效的细胞递送。
Bioconjug Chem. 2019 Feb 20;30(2):263-272. doi: 10.1021/acs.bioconjchem.8b00732. Epub 2018 Dec 5.
9
Viral escape from endosomes and host detection at a glance.病毒从内体逃逸和宿主检测一目了然。
J Cell Sci. 2018 Aug 3;131(15):jcs216259. doi: 10.1242/jcs.216259.
10
Influenza Hemagglutinin Protein Stability, Activation, and Pandemic Risk.流感血凝素蛋白的稳定性、激活及大流行风险
Trends Microbiol. 2018 Oct;26(10):841-853. doi: 10.1016/j.tim.2018.03.005. Epub 2018 Apr 19.